Aclaris Therapeutics (ACRS) Reports In-Line Q4 EPS, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. IBM
5. META
6. MU
7. ACN
8. NVDA
9. BLZE
10. PRIM

Go back to Aclaris Therapeutics (ACRS) Reports In-Line Q4 EPS, Revenues Beat
(NASDAQ: ACRS) Delayed: 4.92 +0.08 (1.65%)
Previous Close $4.84    52 Week High $33.88 
Open $4.77    52 Week Low $14.12 
Day High $5.12    P/E N/A 
Day Low $4.77    EPS $0.00 
Volume 1,865,160